CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Trilogene Seeds has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Agricultural Biotech Companies - 2022 ,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Matthew Haddad, CEO.

Trilogene Seeds
Expediting High-Quality Hemp Cultivation with Cutting-Edge Genomics

Trilogene Seeds

Matthew Haddad, Trilogene Seeds | Life Science Review | Top Agricultural Biotech CompaniesMatthew Haddad, CEO
In the wake of widespread cannabis legalization across several parts of the globe, there has been significant attention from investors, manufacturers, and researchers on its safe use and quality, with a goal to industrialize its use and make the most of a potential multi-billion-dollar market. As a result, cannabis growers or farmers have become overly cautious about quality, rather than focusing on increasing yields. This is where Colorado-based Trilogene Seeds is stepping into the picture, freeing farmers of production-related concerns by unleashing the combined power of traditional breeding methods and genomic technologies.

Hemp farmers are now considering multiple factors before even planting their crop. They are seeking assurances that the hemp seeds they buy will yield as promised and if the crop will be able to resist field stress and adapt to a particular climate. Most importantly, they worry that their plants will “go hot,” crossing the crucial low-THC threshold (0.3 percent) approved by the federal government.

With a footprint in 29 countries across the globe, Trilogene Seeds is increasing the efficiency of a farmer’s growing operations by eliminating all these concerns. With its feminized hemp seeds and cutting-edge cultivars, the company offers farmers strains that adapt well to specific climates and photoperiods, with a boost from its specialized cultivation techniques.

“By leveraging cutting-edge genomic technologies, we are helping farmers effortlessly bring superior hemp products to market while meeting the rigorous regulatory standards set by governing entities,” says Matthew Haddad, CEO of Trilogene Seeds.

Hemp farmers risk losing their crop and live under the constant threat of criminal charges if their hemp crosses the FDA compliant THC levels. As a solution to this prevailing market challenge, Trilogene Seeds created Pandora, the world’s first THC null, high-CBD hemp cultivar. Using RNA interference (RNAi) technology, genetic pathways that produce THC in a cannabis plant are silenced, enabling the global hemp industry to cultivate crops without violating THC-limiting laws.

What truly adds a differentiating edge to Trilogene Seeds’ solutions is how they not only help farmers grow better crops, but also how they distribute them. In line with all the latest industry knowledge regarding in-demand hemp varietals and their current market demands, the company targets specific cannabinoids, compounds, and characteristics at the very first stage of a hemp plant’s life cycle. Based on these parameters, Trilogene Seeds recommends the ideal genetic profile to a particular farmer and helps them grow what buyers are waiting for, ensuring a seamless hemp supply chain. Take the case of a Colorado-based hemp farmer, who exports smokable flowers to Europe. He was unable to meet demand because his crops kept breaching the THC threshold approved in Europe. With his supply chain disrupted, he turned to Trilogene Seeds, and used its advanced CBG cultivar to overcome all compliance-related challenges, leading to a greatly-enhanced overseas distribution highway.

By leveraging cutting-edge genomic technologies, we are helping farmers effortlessly bring superior hemp products to market while meeting the rigorous regulatory standards set by governing entities

To date, the company has released more than 60 new genetic profiles throughout most of the U.S. Having steadily established itself as the largest cannabis seed company in the world, Trilogene Seeds is building on its success to endorse a broad scope of genetic development projects in the near future and devise novel techniques to assist the farmer in troubleshooting operations. “Trilogene Seeds is the right fit for any grower who wants expert assistance at each level of cannabis cultivation—from choosing a really productive seed to having constant support all the way to post-processing sales,” states Haddad.

Top 10 Agricultural Biotech Companies - 2022
Current Issue

Company : Trilogene Seeds

Management
Matthew Haddad, CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/trilogene-seeds